Letters in Drug Design & Discovery logo Bentham Science Publishers logo

Letters in Drug Design & Discovery publishes original letters on all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis will be on publishing quality papers very rapidly. Letters will be processed rapidly by taking full advantage of Internet technology for both the submission and review of manuscripts. The journal is essential reading to all pharmaceutical scientists involved in research in drug design and discovery.

Publisher: Bentham Science Publishers

Volume 2, Number 6, September 2005
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Addendum

Graphical Abstracts
pp. i-iv(4)

Review article

Thermodynamic Aspects of Cancer: Possible Role of Negative Entropy in Tumor Growth, its Relation to Kinetic and Genetic Resistance
pp. 429-438(10)
Authors: Molnar, Joseph; Thornton, Barry S.; Molnar, Annamaria; Gaal, Dezso; Luo, Liaofu; Bergmann-Leitner, Elke S.

Combined Treatment with Octreotide, Galanin and Serotonin in Gastrointestinal Malignancies
pp. 439-443(5)
Author: El-Salhy, Magdy

Discovery, Structural Determination and Anticancer Activities of Lactucinlike Guaianolides
pp. 444-450(7)
Authors: Ren, Yulin; Zhou, Yawei; Chen, Xiaozhuo; Ye, Yunhua

Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part I: Amides and Ureas
pp. 451-455(5)
Authors: Crescenzi, B.; Poma, M.; Ontoria, J. M.; Marchetti, A.; Nizi, E.; Matassa, V. G.; Gardelli, C.

Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part II: Sulfonamides
pp. 456-461(6)
Authors: Ponzi, S.; Giuliano, C.; Donghi, M.; Poma, M.; Matassa, V. G.; Stansfield, I.

Micro Arrayed Compound Screening (mgrARCS) for Inhibitors of Methionine Aminopeptidase Type 2
pp. 462-469(8)
Authors: Fan, Yihong; Wang, Jieyi; Lou, Pingping; Henkin, Jack; Kofron, James L.; Burns, David J.; Warrior, Usha; Anderson, Steven N.

Antiretroviral Therapy: Is it the Right Time for New Strategies?
pp. 470-474(5)
Authors: Abrescia, N.; D'Abbraccio, M.; Busto, A.; Maddaloni, A.; Figoni, M.; De Marco, M.

Selection of a Catalytically Active Enzyme In Vivo Via Phage Display of its Product
pp. 475-478(4)
Authors: Taki, T.; Fujita, S.; Taira, K.

Redox Active Iron at the Center of Oxidative Stress in Alzheimer Disease
pp. 479-482(4)
Authors: Honda, Kazuhiro; Moreira, Paula I.; Liu, Quan; Siedlak, Sandra L.; Zhu, Xiongwei; Smith, Mark A.; Perry, George

Identifying Protein Binding Sites and Optimal Ligands
pp. 483-489(7)
Authors: Beuscher, Albert; Olson, Arthur J.; Goodsell, David S.

Immunomodulatory Properties of Synthetic Imidazolone Derivatives
pp. 490-496(7)
Authors: Mesaik, M. A.; Khan, K. M.; Rahat, S.; Zia-Ullah, Zia-Ullah; Choudhary, M. I.; Murad, S.; Abdullah, N. R.; Atta-ur-Rahman, Atta-ur-Rahman; Ahmad, A.; Siddiqui, R. A.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A